Please use this identifier to cite or link to this item:
https://doi.org/10.2147/TCRM.S221059
Title: | Using patient profiles to guide the choice of antihistamines in the primary care setting in malaysia: Expert consensus and recommendations | Authors: | Baharudin, A. Latiff, A.H.A. Woo, K. Yap, F.B.-B. Tang, I.P. Leong, K.F. Chin, W.S. Wang, D.Y. |
Keywords: | Antihistamines Malaysia Patient profiling Primary care |
Issue Date: | 2019 | Publisher: | Dove Medical Press Ltd. | Citation: | Baharudin, A., Latiff, A.H.A., Woo, K., Yap, F.B.-B., Tang, I.P., Leong, K.F., Chin, W.S., Wang, D.Y. (2019). Using patient profiles to guide the choice of antihistamines in the primary care setting in malaysia: Expert consensus and recommendations. Therapeutics and Clinical Risk Management 15 : 1267-1275. ScholarBank@NUS Repository. https://doi.org/10.2147/TCRM.S221059 | Rights: | Attribution-NonCommercial 4.0 International | Abstract: | H1-antihistamines are recognized to be effective for conditions such as allergic rhinitis and chronic spontaneous urticaria. However, management of such conditions in the real-world primary care setting may be challenging due to diverse patient-specific considerations, the wide range of antihistamines available, choice of other treatment modalities, and the complexity of interpreting specialist treatment algorithms. Despite regular updates to international guidelines, regional/national surveys of healthcare professionals show a clear gap between guidelines and real-world practice, particularly at the primary care level. This article thus presents the consensus opinion of experts from relevant specialties in Malaysia – allergology, pediatrics, otorhinolaryngology, and dermtology – on harmonizing the use and choice of antihistamines in primary care. Patient profiling is recommended as a tool to guide primary care practitioners in prescribing the appropriate antihistamine for each patient. Patient profiling is a three-step approach that involves 1) identifying the individual’s needs; 2) reviewing patient-specific considerations; and 3) monitoring treatment response and referral to specialists in more severe or difficult-to-treat cases. Concurrently, guidelct 3ines should be reviewed and updated periodically to include recommendations that are easily actionable for primary care practitioners. © 2019 Baharudin et al. terms.php and incorporate. | Source Title: | Therapeutics and Clinical Risk Management | URI: | https://scholarbank.nus.edu.sg/handle/10635/212364 | ISSN: | 11766336 | DOI: | 10.2147/TCRM.S221059 | Rights: | Attribution-NonCommercial 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_2147_TCRM_S221059.pdf | 1.52 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License